On this World Malaria Day, the world is calling for an end to malaria. We must increase efforts to ensure that antimalarials used to treat malaria are safe, effective and of good-quality. Here are some ways we can close the treatment gap and provide the millions of people newly infected with malaria each year with reliable, quality-assured medicines.
Medicines quality is at the center of CePAT’s work. Equipped with a new lab and expanded capabilities, CePAT is now tackling barriers to quality and hopes to change the odds that African’s will receive quality-assured medicines.
Patrick Lukulay, USP’s VP of GHIP–Africa, discusses plans to leverage his new post in Accra, Ghana to advance pharmaceutical quality in Africa. Countering fallacies in drug quality through advocacy and working to help build an enabling environment that can sustain systems for effective regulation of medical products, he says, are needed for this to happen.
With assistance from USP's Promoting the Quality of Medicines (PQM) program, Guatemala’s official medicines control laboratory has retained their ISO 17025 accreditation, a major milestone in its quest to combat the proliferation of poor quality medicines within its borders.
This World TB Day, Promoting the Quality of Medicines (PQM) program celebrates its achievement and commitment to taking an active role in reaching the millions of people with TB who are “missed” by health systems each year and do not get the care they need.